Benitec Biopharma Limited Share Based Compensation of Revenue

Share Based Compensation of Revenue of BNTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Share Based Compensation of Revenue growth rates and interactive chart.


Highlights and Quick Summary

  • Share Based Compensation of Revenue for the quarter ending June 30, 2022 was 0.0% (a -100.0% decrease compared to previous quarter)
  • Year-over-year quarterly Share Based Compensation of Revenue decreased by NaN%
  • Annual Share Based Compensation of Revenue for 2022 was 1191.78% (a 10.91% increase from previous year)
  • Annual Share Based Compensation of Revenue for 2021 was 1074.58% (a Infinity% increase from previous year)
  • Annual Share Based Compensation of Revenue for 2021 was 0.0% (a -100.0% decrease from previous year)
  • Twelve month Share Based Compensation of Revenue ending June 30, 2022 was 1160.0% (a -10.13% decrease compared to previous quarter)
  • Twelve month trailing Share Based Compensation of Revenue increased by Infinity% year-over-year
Trailing Share Based Compensation of Revenue for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
1160.0% 1290.79% 3531.03% 0.0%
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Share Based Compensation of Revenue of Benitec Biopharma Limited

Most recent Share Based Compensation of Revenueof BNTC including historical data for past 10 years.

Interactive Chart of Share Based Compensation of Revenue of Benitec Biopharma Limited

Benitec Biopharma Limited Share Based Compensation of Revenue for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 0.0% 400.0% 1191.78%
2021 956.0% 0.0% 13950.0% 23500.0% 1074.58%
2020 8200.0% 69.09% -158.33% 642.86% 232.35%
2019 0.0% 166.67% 5.51%
2018 9.22%
2017 0.0% 0.0%
2016 0.0% 43.07%
2015 37.84%
2014 25.85%
2013 35.43%

Business Profile of Benitec Biopharma Limited

Sector: Healthcare
Industry: Biotechnology